NetworkNewsBreaks – Neutra Corp. (NTRR) Executes

NetworkNewsBreaks – Neutra Corp. (NTRR) Executes LOI with Orgaceutical

Neutra Corp. (OTCQB: NTRR), an early-stage research and development company, this morning announced that it has executed a letter of intent (“LOI”) with Orgaceutical that could initiate the joint development of various additional hemp-based medicinal products. Per the agreement, Harrisburg, PA-based Orgaceutical will provide Neutra access to its formal research results to explore the use of cannabinoids as antioxidants and neuro-protectants. In addition, Neutra will obtain rights to a federally registered hemp trademark and a license for hemp cultivation issued by the Commonwealth of Pennsylvania’s Department of Agriculture. “This LOI will propel us into an excellent position for research and development of exciting new applications for hemp-based medicinal CBD products,” Neutra CEO Sydney Jim stated in the news release. “With the cultivation license, we’ll have a constant and consistent supply of quality hemp under a vertically integrated cultivation model. With the research license, we’ll be free to explore new uses for hemp and products derived from it. Finally, with the trademark, we’ll have a federally protected brand name to pair with our existing VIVIS product line.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer